![Joseph Loscalzo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joseph Loscalzo
Presidente presso
IONIS PHARMACEUTICALS, INC.
Patrimonio netto: 3 M $ in data 31/05/2026
Profilo
Il dottor Joseph Loscalzo, MD PhD, è consulente di Mi3 Venture Partners Management LLC. È professore di Wade e presidente del dipartimento di medicina, professore di biochimica e direttore del Whitaker Cardiovascular Institute presso la Boston University School of Medicine, nonché medico capo del Boston Medical Center. È uno dei fondatori di NitroMed, Inc. e fa parte del suo consiglio di amministrazione e presiede il suo comitato consultivo scientifico. Nel 2004 è diventato caporedattore di Circulation, una delle principali riviste scientifiche di cardiologia. Il Dr. Loscalzo ha ricevuto la sua laurea, summa cum laude, il suo dottorato in biochimica e il suo M.D. presso l'Università della Pennsylvania. È entrato a far parte della facoltà di Harvard e del personale del Brigham and Women's Hospital nel 1984. È entrato a far parte della facoltà dell'Università di Boston nel 1994, prima come primario di cardiologia e, nel 1997, come presidente di medicina. Il Dr. Loscalzo è l'immediato passato presidente del Consiglio Cardiovascolare dell'American Board of Internal Medicine e l'immediato passato presidente del Consiglio dei Consiglieri Scientifici dell'NHLBI. È stato Visiting Professor in molte istituzioni ed è autore o coautore di più di 400 pubblicazioni scientifiche e 20 libri. Ha anche ricevuto molte sovvenzioni dal NIH e dall'industria per il suo lavoro nelle aree della biologia vascolare, della trombosi e dell'aterosclerosi negli ultimi venti anni.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 04/05/2026 | 36.330 ( 0,02% ) | 3 M $ | 31/05/2026 | |
| 20/04/2026 | 168.750 ( 0,16% ) | 190 688 $ | 31/05/2026 |
Posizioni attive di Joseph Loscalzo
| Società | Posizione | Inizio |
|---|---|---|
| IONIS PHARMACEUTICALS, INC. | Presidente | 02/06/2021 |
| CYPHERPUNK TECHNOLOGIES INC. | Direttore/Membro del Consiglio | 01/01/2016 |
Brigham Medical Research & Educational Foundation, Inc. | Presidente | - |
Brigham Community Practices, Inc. | Direttore/Membro del Consiglio | - |
Broadview Ventures, Inc.
 Broadview Ventures, Inc. Investment ManagersFinance Broadview Ventures invests in companies located across the globe, primarily in North America, Europe and Israel. The firm targets companies operating in the fields of healthcare and technology sectors. It provides financing for seed and early-stage capital requirements. The firm makes follow-on investments. | Consulente / Consigliere | - |
Scipher Medicine Corp.
 Scipher Medicine Corp. Miscellaneous Commercial ServicesCommercial Services Provides RNA data analysis for the treatment of autoimmune diseases and develops AI platform | Fondatore | 01/01/2013 |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Corporate Officer/Principal | - |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
The Brigham & Women's Hospital, Inc.
 The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services Provides health care services | Corporate Officer/Principal | - |
| ░░░░░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
Precedenti posizioni note di Joseph Loscalzo
| Società | Posizione | Fine |
|---|---|---|
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░ ░░░░░ ░░ ░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formazione di Joseph Loscalzo
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
85
Relazioni di 1° grado
25
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 25 |
|---|---|
Ionis Pharmaceuticals, Inc.
 Ionis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antisense drugs | Health Technology |
NitroMed, Inc.
 NitroMed, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies pharmaceuticals | Health Technology |
Cardiovascular Sciences, Inc.
 Cardiovascular Sciences, Inc. Other Consumer ServicesConsumer Services Develops novel technology platform | Consumer Services |
TargAnox, Inc.
 TargAnox, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics to prevent oxidative stress diseases | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Brigham & Women's Hospital, Inc.
The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services Provides health care services | Health Services |
CB Health Ventures
 CB Health Ventures Investment ManagersFinance CB Health Ventures focuses on investment opportunities in healthcare services, medical information technology, biotechnology and genomics | Finance |
National Institutes of Health
National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Government |
American Heart Association, Inc.
 American Heart Association, Inc. Miscellaneous Commercial ServicesCommercial Services Operates a voluntary health organization | Commercial Services |
Brigham & Women's Faulkner Hospital, Inc.
 Brigham & Women's Faulkner Hospital, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit organization that Provides health care services | Commercial Services |
Boston Medical Center
 Boston Medical Center Hospital/Nursing ManagementHealth Services Provides healthcare services | Health Services |
Mass General Brigham, Inc.
 Mass General Brigham, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit integrated healthcare system | Commercial Services |
American Board of Internal Medicine
 American Board of Internal Medicine Miscellaneous Commercial ServicesCommercial Services Operates self-appointed physician evaluation organization | Commercial Services |
Excel Medical Ventures LLC
 Excel Medical Ventures LLC Investment ManagersFinance Excel Medical Ventures invests in companies located in the United States. The firm focuses on companies operating in agriculture, energy, materials, IT, defense, healthcare sectors such as healthcare IT & services, diagnostics, medical devices, and life sciences platforms. It participates in early to late stage transactions. | Finance |
National Heart, Lung & Blood Institute
 National Heart, Lung & Blood Institute General GovernmentGovernment Promotes the prevention and treatment of heart, lung and blood diseases | Government |
Broadview Ventures, Inc.
Broadview Ventures, Inc. Investment ManagersFinance Broadview Ventures invests in companies located across the globe, primarily in North America, Europe and Israel. The firm targets companies operating in the fields of healthcare and technology sectors. It provides financing for seed and early-stage capital requirements. The firm makes follow-on investments. | Finance |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nivalis Therapeutics, Inc.
 Nivalis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of products for patients with cystic fibrosis | Health Technology |
Whitaker Cardiovascular Institute
 Whitaker Cardiovascular Institute The Whitaker Cardiovascular Institute is a research laboratory located in the Department of Medicine at Boston University School of Medicine. The lab focuses on studying endothelial cells and understanding vascular diseases, with a particular interest in the role of endothelial cells in the cardiovascular system. The company's research interests include understanding the molecular and cellular mechanisms that regulate vascular inflammation, endothelial dysfunction, pulmonary microvascular injury in sepsis, arterial vascular dysfunction, and atherosclerosis, developing non-invasive methods to measure in vivo vascular function, and exploring endothelial cell-targeted therapies for lung and cardiovascular diseases. The laboratory has a strong track record of research productivity and has expanded their research to cover topics such as cardiovascular physiopathology, redox biology, redOX proteomics, and optical vascular imaging. Whitaker Cardiovascular Institute is based in Boston, MA. | |
Scipher Medicine Corp.
Scipher Medicine Corp. Miscellaneous Commercial ServicesCommercial Services Provides RNA data analysis for the treatment of autoimmune diseases and develops AI platform | Commercial Services |
Leap Therapeutics, Inc.
 Leap Therapeutics, Inc. BiotechnologyHealth Technology Engages in clinical stage immuno-oncology | Health Technology |
Brigham Community Practices, Inc. | |
Brigham Medical Research & Educational Foundation, Inc. |
